Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Miller

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
Physical Chemistry Chemical Physics : PCCP|January 14, 2026
Approximate quantum circuit compilation for proton-transfer kinetics on quantum processorsArseny Kovyrshin, Dilhan Manawadu, Edoardo Altamura, et al.
JAMA Neurology|March 27, 2013
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosisBenjamin M Greenberg, Laura Balcer, Peter A Calabresi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2019
Dissociable cognitive patterns related to depression and anxiety in multiple sclerosisVictoria M Leavitt, Rachel Brandstadter, Michelle Fabian, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 22, 2022
Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying TherapiesTjalf Ziemssen, Virender Bhan, Jeremy Chataway, et al.
Journal for Immunotherapy of Cancer|February 5, 2024
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cellsGregory P Botta, Joseph Chao, Hong Ma, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 28, 2017
Cerebellar lobule atrophy and disability in progressive MSSirio Cocozza, Maria Petracca, Enricomaria Mormina, et al.
Multiple Sclerosis and Related Disorders|January 11, 2023
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapyIlana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapyIlana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|October 27, 2005
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbitsJoseph M Harrison, Randolph D Glickman, Charles S Ballentine, et al.
The Lancet. Neurology|March 17, 2018
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extensionRaju Kapoor, Pei-Ran Ho, Nolan Campbell, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Physical Chemistry Chemical Physics : PCCP|January 14, 2026
Approximate quantum circuit compilation for proton-transfer kinetics on quantum processorsArseny Kovyrshin, Dilhan Manawadu, Edoardo Altamura, et al.
JAMA Neurology|March 27, 2013
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosisBenjamin M Greenberg, Laura Balcer, Peter A Calabresi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2019
Dissociable cognitive patterns related to depression and anxiety in multiple sclerosisVictoria M Leavitt, Rachel Brandstadter, Michelle Fabian, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 22, 2022
Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying TherapiesTjalf Ziemssen, Virender Bhan, Jeremy Chataway, et al.
Journal for Immunotherapy of Cancer|February 5, 2024
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cellsGregory P Botta, Joseph Chao, Hong Ma, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 28, 2017
Cerebellar lobule atrophy and disability in progressive MSSirio Cocozza, Maria Petracca, Enricomaria Mormina, et al.
Multiple Sclerosis and Related Disorders|January 11, 2023
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapyIlana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapyIlana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|October 27, 2005
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbitsJoseph M Harrison, Randolph D Glickman, Charles S Ballentine, et al.
The Lancet. Neurology|March 17, 2018
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extensionRaju Kapoor, Pei-Ran Ho, Nolan Campbell, et al.
Pageof 17